FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels
FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels
FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page